Concepedia

Stefan Leggewie

SL

Statistics

Publications

9

Citations

1.8K

H-Index

9

Active since

2000

Affiliations

Universitäts-Herzzentrum Freiburg-Bad Krozingen(Current)

Inserm

Brigham and Women's Hospital

Uppsala University

University of Colorado Denver

Stefan Leggewie is an author at Universitäts-Herzzentrum Freiburg-Bad Krozingen specializing in medicine, pharmacotherapy, and clinical pharmacology.

Publications per year

2000–2024

9

Publications

9

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

Stefanie Schüpke, Franz‐Josef Neumann, Maurizio Menichelli et al. · New England Journal of Medicine · 2019 · 789 citations · Full text

, , +17

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen et al. · The Lancet · 2017 · 590 citations · Full text

, , +17

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 148 citations · Full text

, , +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

, , +17

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

Kausik K. Ray, Carlos Aguíar, Marcello Arca et al. · European Journal of Preventive Cardiology · 2024 · 70 citations · Full text

, , +17

1–5 of 9